Background
Background Substance use may be a Substance use may be a risk factor for the onset of schizophrenia. risk factor for the onset of schizophrenia.
Aims Aims To examine the association
To examine the association between substance use and age atonsetin between substance use and age at onset in a UK, inner-city sample of people with a UK, inner-city sample of people with recent-onset schizophrenia. recent-onset schizophrenia.
Method Method
The study sample consisted of
The study sample consisted of 152 people recruited to the West London 152 people recruited to the West London First-Episode Schizophrenia Study. SelfFirst-Episode Schizophrenia Study. Selfreported data on drug and alcohol use, as reported data on drug and alcohol use, as well as information on age at onset of well as information on age at onset of psychosis, were collected. Mental state, psychosis, were collected.Mental state, cognition (IQ, memory and executive cognition (IQ, memory and executive function) and social function were also function) and social function were also assessed. assessed.
Results

In total, 60% ofthe participants Intotal, 60% ofthe participants were smokers, 27% reported a history of were smokers, 27% reported a history of problems with alcohol use, 35% reported problems with alcohol use, 35% reported current substance use (not including current substance use (not including alcohol), and 68% reported lifetime alcohol), and 68% reported lifetime substance use (cannabis and substance use (cannabis and psychostimulants were most commonly psychostimulants were most commonly used).Cannabis use and gender had used).Cannabis use and gender had independent effects on age at onset of independent effects on age at onset of psychosis, after adjusting for alcohol psychosis, after adjusting for alcohol misuse and use of other drugs. misuse and use of other drugs.
Conclusions Conclusions The strong association
The strong association between self-reported between self-reported cannabis use and cannabis use and earlier onset of psychosis provides further earlier onset of psychosis provides further evidence that schizophrenia may be evidence that schizophrenia may be precipitated by cannabis use and/or that precipitated by cannabis use and/or that the early onset of symptoms is a risk factor the early onset of symptoms is a risk factor for cannabis use. for cannabis use.
Declaration of interest Declaration of interest None.FundNone.Funding detailed in the Acknowledgements. ing detailed in the Acknowledgements.
Substance use in people with schizophrenia Substance use in people with schizophrenia is more common than in the general popuis more common than in the general population, and is associated with poor clinical lation, and is associated with poor clinical and social outcomes (Blanchard and social outcomes (Blanchard et al et al, , 2000; Kavanagh 2000; Kavanagh et al et al, 2002) . Substance , 2002) . Substance use may also be a risk factor for the onset use may also be a risk factor for the onset of the disorder (Smit of the disorder (Smit et al et al, 2004; Semple , 2004; Semple et al et al, 2005) , and the use of cannabis in ado-, 2005) , and the use of cannabis in adolescence has been reported to increase the lescence has been reported to increase the risk of developing symptoms of schizorisk of developing symptoms of schizophrenia in adulthood (Tsapakis phrenia in adulthood (Tsapakis et al et al, , 2003) . One piece of supportive evidence is 2003). One piece of supportive evidence is that some first-episode studies have found that some first-episode studies have found an earlier age at onset for individuals with an earlier age at onset for individuals with a history of comorbid substance use (Rabia history of comorbid substance use (Rabinowitz nowitz et al et al, 1998; Mastrigt , 1998 ). The present study was designed to assess the influence of was designed to assess the influence of substance use on the age at onset of psysubstance use on the age at onset of psychosis in first-episode schizophrenia in chosis in first-episode schizophrenia in West London, and to examine the relationWest London, and to examine the relationship between a history of comorbid ship between a history of comorbid substance use and measures of the nature substance use and measures of the nature and severity of symptoms, and social and and severity of symptoms, and social and neuropsychological function. neuropsychological function.
METHOD METHOD Participants Participants
Individuals were recruited as part of a prosIndividuals were recruited as part of a prospective longitudinal study of first-episode pective longitudinal study of first-episode schizophrenia in West London. Details of schizophrenia in West London. Details of the study design and entry criteria can be the study design and entry criteria can be found elsewhere (Hutton found elsewhere (Hutton et al et al, 1998) , as , 1998), as can information on symptom severity, adcan information on symptom severity, adherence to treatment, duration of untreated herence to treatment, duration of untreated psychosis (DUP) and cognitive function in psychosis (DUP) and cognitive function in samples derived from this study (Barnes samples derived from this study (Barnes et et al al, 2000; Joyce , 2000; Joyce et al et al, 2002; Mutsatsa , 2002; Mutsatsa et al et al, , 2003) . The patients who were eligible for 2003). The patients who were eligible for inclusion in this study were aged between inclusion in this study were aged between 16 and 50 years, had received no more than 16 and 50 years, had received no more than 12 weeks of antipsychotic medication, and 12 weeks of antipsychotic medication, and in most cases were seen at the time of their in most cases were seen at the time of their first admission to hospital. For each first admission to hospital. For each patient, a diagnosis of DSM-IV (American patient, a diagnosis of DSM-IV (American Psychiatric Association, 1994) schizoPsychiatric Association, 1994) schizophrenia or schizophreniform disorder was phrenia or schizophreniform disorder was confirmed at diagnostic review by two confirmed at diagnostic review by two senior clinicians (E.M.J. and T.R.E.B.). senior clinicians (E.M.J. and T.R.E.B.).
Assessments Assessments
Basic demographic data were collected Basic demographic data were collected from the patients and their case notes. Lifefrom the patients and their case notes. Lifetime alcohol and substance use were time alcohol and substance use were recorded using the Substance Use Rating recorded using the Substance Use Rating Scale, patient version (SURSp; Duke Scale, patient version (SURSp; Duke et al et al, , 1994) . This scale allows the identification 1994). This scale allows the identification of patients with drinking problems, and of patients with drinking problems, and elicits any evidence of alcohol dependency, elicits any evidence of alcohol dependency, as well as collecting information on the as well as collecting information on the nature of current drug use (within the past nature of current drug use (within the past month) and previous drug use. month) and previous drug use.
Information relating to the date of Information relating to the date of onset of psychotic symptoms was elicited onset of psychotic symptoms was elicited using a modified questionnaire using a modified questionnaire (Loebel (Loebel et et al al, 1992; Barnes , 1992; Barnes et al et al, 2000) . Relevant in-, 2000) . Relevant information was also collected from the clinformation was also collected from the clinical case notes, and by questioning the ical case notes, and by questioning the patient and their relatives and/or carers. Any patient and their relatives and/or carers. Any discrepancy between the different sources discrepancy between the different sources was discussed within the research team, and was discussed within the research team, and the information that was deemed to be most the information that was deemed to be most reliable was used. The DUP, namely the time reliable was used. The DUP, namely the time from onset of psychotic symptoms to first from onset of psychotic symptoms to first treatment with antipsychotic medication, treatment with antipsychotic medication, was calculated for each patient. was calculated for each patient.
Global severity of illness was assessed Global severity of illness was assessed using the Clinical Global Impression Scale using the Clinical Global Impression Scale (CGI; Guy, 1976) . Mental state was (CGI; Guy, 1976) . Mental state was assessed using the Scale for Assessment assessed using the Scale for Assessment of Positive Symptoms and the Scale for of Positive Symptoms and the Scale for Assessment of Negative Symptoms (SAPS Assessment of Negative Symptoms (SAPS and SANS respectively; Andreasen, 1990). and SANS respectively; Andreasen, 1990) . Scores for three symptom-derived synScores for three symptom-derived syndromes of schizophrenia were calculated dromes of schizophrenia were calculated for each patient by adding together the for each patient by adding together the global sub-scale scores pertaining to each global sub-scale scores pertaining to each factor, and dividing by the maximum factor, and dividing by the maximum possible score to give a value between 0 possible score to give a value between 0 and 1 for each factor. The syndromes were and 1 for each factor. The syndromes were categorised as follows: positive syndrome categorised as follows: positive syndrome (SAPS hallucinations and delusions); dis-(SAPS hallucinations and delusions); disorganisation syndrome (SAPS bizarre organisation syndrome (SAPS bizarre behaviour and positive formal thought behaviour and positive formal thought disorder); and negative syndrome (all SANS disorder); and negative syndrome (all SANS sub-scales). The Comprehensive Psychosub-scales). The Comprehensive Psychopathological Rating Scale (CPRS; Asberg pathological Rating Scale (CPRS; Å sberg et al et al, 1978) was also administered, , 1978) was also administered, from which a score for the 10-item from which a score for the 10-item ) and a test of spatial working memory. We have described these working memory. We have described these tests, the performance measures used and tests, the performance measures used and the derivation of the test scores in our the derivation of the test scores in our patients elsewhere (Hutton patients elsewhere (Hutton et al et al, 1998) . , 1998).
Data analysis Data analysis
The data were analysed using the Statistical The data were analysed using the Statistical Package for the Social Sciences, version 12 Package for the Social Sciences, version 12 for Windows for Windows. In a comparison of patients . In a comparison of patients with and without a history of substance with and without a history of substance use, the use, the t t-test was employed for continuous -test was employed for continuous data and the data and the w w 2 2 test was used for categorical test was used for categorical data. Age at onset of psychosis was used as data. Age at onset of psychosis was used as the outcome variable in a linear regression the outcome variable in a linear regression model, and potentially influential variables model, and potentially influential variables (relating to gender and substance use) were (relating to gender and substance use) were entered as independent variables. entered as independent variables.
RESULTS RESULTS
Information on lifetime substance use was Information on lifetime substance use was collected at interview for 152 patients collected at interview for 152 patients (110 men and 42 women) with DSM-IV (110 men and 42 women) with DSM-IV schizophrenia or schizophreniform disorschizophrenia or schizophreniform disorder, who were studied at the time of their der, who were studied at the time of their first presentation to psychiatric services, first presentation to psychiatric services, but the data were incomplete in 6 cases. but the data were incomplete in 6 cases. On the basis of these data, which were obOn the basis of these data, which were obtained using the SURSp, the sample was tained using the SURSp, the sample was divided into two subgroups, namely those divided into two subgroups, namely those reporting a history of alcohol misuse reporting a history of alcohol misuse (problem drinking, with or without evi-(problem drinking, with or without evidence of dependent drinking) and/or subdence of dependent drinking) and/or substance use ( stance use (n n¼110), and those with no 110), and those with no such history ( such history (n n¼42). In the former group, 42). In the former group, most patients described both alcohol mismost patients described both alcohol misuse and substance use, and only 5 patients use and substance use, and only 5 patients reported current or lifetime problem drinkreported current or lifetime problem drinking or evidence of dependent drinking in ing or evidence of dependent drinking in the absence of any other substance use. the absence of any other substance use. The clinical characteristics of the two The clinical characteristics of the two subgroups are listed in Table 1 . Further subgroups are listed in Table 1 . Further sub-categorisation of the sample on the sub-categorisation of the sample on the basis of the reported profile of substances basis of the reported profile of substances used was not possible because of the overused was not possible because of the overlap in substances used. For example, 90% lap in substances used. For example, 90% of the patients with a history of any type of the patients with a history of any type of substance use reported the use of of substance use reported the use of cannabis. cannabis.
For the total sample, the median DUP For the total sample, the median DUP was 24 weeks. The mean DUP did not was 24 weeks. The mean DUP did not differ significantly between those with and differ significantly between those with and without substance use (see Table 1 ). Howwithout substance use (see Table 1 ). However, the patients with a reported lifetime ever, the patients with a reported lifetime history of substance use were significantly history of substance use were significantly younger at the time of the assessment younger at the time of the assessment ( (t t¼2.45, d.f.
2.45, d.f.¼148, 148, P P¼0.012), and were 0.012), and were also significantly also significantly younger at the onset of younger at the onset of their psychotic symptoms ( their psychotic symptoms (t t¼2.15, 2.15, d.f. d.f.¼148, 148, P P¼0.033). Linear regression 0.033). Linear regression analysis was performed with age at onset analysis was performed with age at onset as the outcome variable and with the as the outcome variable and with the following four independent variables: following four independent variables: gender; any report of alcohol misuse (probgender; any report of alcohol misuse (problem or dependent drinking); any report of lem or dependent drinking); any report of cannabis use; and any report of substance cannabis use; and any report of substance use other than cannabis use. Alcohol misuse use other than cannabis use. Alcohol misuse and any substance use (other than cannabis and any substance use (other than cannabis use) were not significant in relation to age use) were not significant in relation to age at onset (estimated mean age 1.6 years at onset (estimated mean age 1.6 years older in patients reporting alcohol misuse, older in patients reporting alcohol misuse, 95% CI 95% CI 7 71.1 to 4.2, 1.1 to 4.2, P P¼0.2; estimated 0.2; estimated mean age 1.9 years older in users of drugs mean age 1.9 years older in users of drugs other than cannabis, 95% CI other than cannabis, 95% CI 7 70.9 to 4.9, 0.9 to 4.9, P P¼0.2 0.2). However, gender and cannabis ). However, gender and cannabis use were found to be significant. The results use were found to be significant. The results indicate that in this sample the age at onset indicate that in this sample the age at onset of psychosis was on average 4.2 years older of psychosis was on average 4.2 years older for women (95% CI 1.7-6.8, for women (95% CI 1.7-6.8, P P¼0.001) 0.001) when adjusted for substance use. Cannabis when adjusted for substance use. Cannabis use was significantly associated with a use was significantly associated with a younger onset by a mean value of 5 years younger onset by a mean value of 5 years (95% CI 1.9-8.1, (95% CI 1.9-8.1, P P¼0.002), adjusted for 0.002), adjusted for gender and substance use other than gender and substance use other than cannabis use. This means that those cannabis use. This means that those patients in the sample who reported that patients in the sample who reported that they had used cannabis had an earlier age they had used cannabis had an earlier age at onset of psychosis than other patients at onset of psychosis than other patients who did not report cannabis use but who who did not report cannabis use but who shared the same profile with regard to the shared the same profile with regard to the other variables (e.g. comparing men who other variables (e.g. comparing men who reported alcohol misuse and use of both reported alcohol misuse and use of both cannabis and other drugs with men who cannabis and other drugs with men who had the same characteristics apart from had the same characteristics apart from the fact that they had not used cannabis). the fact that they had not used cannabis).
We have reported elsewhere (Joyce We have reported elsewhere (Joyce et et al al, 2005 ) that premorbid IQ (measured by , 2005) that premorbid IQ (measured by the NART) was associated with earlier the NART) was associated with earlier onset of psychosis in a sample that was onset of psychosis in a sample that was also derived from the West London Firstalso derived from the West London FirstEpisode Schizophrenia Study. The NART Episode Schizophrenia Study. The NART score score was entered as an additional indepenwas entered as an additional independent variable in the present linear regresdent variable in the present linear regression analysis, and it was found to be sion analysis, and it was found to be significant, whereas cannabis use remained significant, whereas cannabis use remained significant significant (an estimated increase of 0.24
(an estimated increase of 0.24 2 3 8 2 3 8 AUTHOR'S PROOF AUTHOR'S PROOF years in age at onset per unit increase in years in age at onset per unit increase in NART; 95% CI 0.12-0.37, NART; 95% CI 0.12-0.37, P P5 50.0002). 0.0002). Data on the nature and prevalence of Data on the nature and prevalence of alcohol and drug use in those participants alcohol and drug use in those participants who provided a full report are shown in who provided a full report are shown in Table 2 . Cannabis was the substance most Table 2 . Cannabis was the substance most commonly used. In total, 94 patients in commonly used. In total, 94 patients in the sample had used this drug at some time, the sample had used this drug at some time, of whom only 25 patients (27%) had not of whom only 25 patients (27%) had not used other drugs. The other drugs that used other drugs. The other drugs that had been used, in descending order of rehad been used, in descending order of reported use, were amphetamines and stimuported use, were amphetamines and stimulants (including cocaine), ecstasy, lysergic lants (including cocaine), ecstasy, lysergic acid diethylamide (LSD), opiates (including acid diethylamide (LSD), opiates (including heroin), barbiturates and benzodiazepines, heroin), barbiturates and benzodiazepines, other substances (e.g. khat) and phencycliother substances (e.g. khat) and phencyclidine (PCP) dine (PCP). With regard to alcohol misuse, . With regard to alcohol misuse, 40 patients reported a history of problem 40 patients reported a history of problem drinking, of whom 29 patients (72.5%) drinking, of whom 29 patients (72.5%) fulfilled the criteria for dependent drinking. fulfilled the criteria for dependent drinking.
In Table 3 , data for the two patient In Table 3 , data for the two patient subgroups are compared with regard subgroups are compared with regard to the clinical and neuropsychological to the clinical and neuropsychological assessments that were administered. The assessments that were administered. The patients who were substance users had a patients who were substance users had a significantly higher mean CGI score significantly higher mean CGI score ( (t t¼7 72.99, d.f.
2.99, d.f.¼138, 138, P P¼0.003) and there 0.003) and there was a trend towards a higher mean score was a trend towards a higher mean score on the positive symptoms syndrome (halluon the positive symptoms syndrome (hallucinations and delusions) ( cinations and delusions) (t t¼7 71.85, 1.85, d.f. d.f.¼150, 150, P P¼0.066). There was also a trend 0.066). There was also a trend towards an association of substance use towards an association of substance use with male gender ( with male gender (w w 2 2 ¼3.18, d.f.
3.18, d.f.¼1, 1, P P¼0.075). There were no statistically sig-0.075). There were no statistically significant differences between the two groups nificant differences between the two groups with regard to mean SFS total score, mean with regard to mean SFS total score, mean ROMI positive and negative scores or mean ROMI positive and negative scores or mean MADRS total score. Neuropsychological MADRS total score. Neuropsychological test results were only obtained for a subtest results were only obtained for a subsample of the patients (see Table 3 ). Analysample of the patients (see Table 3 ). Analysis of the data revealed no significant sis of the data revealed no significant differences between substance users and differences between substance users and non-users on performance measures for non-users on performance measures for any of the neuropsychological tasks. any of the neuropsychological tasks.
DISCUSSION DISCUSSION
Earlier age at onset Earlier age at onset
We found an earlier age at onset of psychoWe found an earlier age at onset of psychosis in patients who reported a lifetime sis in patients who reported a lifetime history of comorbid substance use. One history of comorbid substance use. One 2 3 9 2 3 9 AUTHOR'S PROOF AUTHOR'S PROOF explanation for this is that the illness is explanation for this is that the illness is precipitated by substance use, although it precipitated by substance use, although it remains uncertain whether this effect is remains uncertain whether this effect is limited to people with a predisposition to limited to people with a predisposition to psychosis (Smit psychosis (Smit et al et al, 2004; Henquet , 2004; Henquet et al et al, , 2005) . Another possible explanation is that 2005). Another possible explanation is that the early onset of symptoms is a risk factor the early onset of symptoms is a risk factor for substance use. The experience of sympfor substance use. The experience of symptoms could make patients vulnerable to toms could make patients vulnerable to substance use, perhaps in an attempt to substance use, perhaps in an attempt to cope with the illness or to self-medicate cope with the illness or to self-medicate (Hambrecht & Hafner, 1996; Addington (Hambrecht & Hä fner, 1996; Addington & Addington, 1998; Degenhardt & Addington, 1998; Degenhardt et al et al, , 2003) . These hypotheses have been ex-2003). These hypotheses have been explored in previous studies by examining plored in previous studies by examining the temporal relationship between the onset the temporal relationship between the onset of schizophrenia and substance use. The of schizophrenia and substance use. The findings have been inconsistent (Hambrecht findings have been inconsistent (Hambrecht & Hafner, 1996 , 2000 , and have generally & Hä fner, 1996 Hä fner, , 2000 , and have generally only addressed the relationship between only addressed the relationship between substance use and the onset of psychotic substance use and the onset of psychotic symptoms, and not the possible relevance symptoms, and not the possible relevance of prodromal symptoms. Furthermore, the of prodromal symptoms. Furthermore, the relatively high proportion of patients who relatively high proportion of patients who reported lifetime substance use in this and reported lifetime substance use in this and other first-episode studies raises the possother first-episode studies raises the possibility that substance-related symptoms ibility that substance-related symptoms could confound retrospective estimation of could confound retrospective estimation of DUP and age at onset. For example, drug-DUP and age at onset. For example, druginduced phenomena may be mistaken for induced phenomena may be mistaken for early symptoms of illness or substance use early symptoms of illness or substance use may mask psychotic symptoms (Larsen may mask psychotic symptoms (Larsen et et al al, 2001 ). In the latter situation, if , 2001). In the latter situation, if patients perceive their early psychotic patients perceive their early psychotic symptoms to be drug-induced, this may symptoms to be drug-induced, this may delay their seeking help for illness and thus delay their seeking help for illness and thus prolong the DUP. Norman & Malla (2002) prolong the DUP. Norman & Malla (2002) proposed more generally that substance use proposed more generally that substance use by people with psychosis may partly reflect by people with psychosis may partly reflect denial of the severity of their illness and of denial of the severity of their illness and of the potential benefit of medical interventhe potential benefit of medical intervention, and may thus be associated with a tion, and may thus be associated with a reduced likelihood of seeking treatment reduced likelihood of seeking treatment soon after the onset of psychosis. However, soon after the onset of psychosis. However, our findings do not support such a view, our findings do not support such a view, insofar as we found no relationship insofar as we found no relationship between a history of substance use and between a history of substance use and DUP. DUP.
Our data do not allow us to determine Our data do not allow us to determine whether or not the use of drugs preceded whether or not the use of drugs preceded the onset of psychotic and/or prodromal the onset of psychotic and/or prodromal symptoms in the majority of patients. symptoms in the majority of patients. Furthermore, the marked overlap between Furthermore, the marked overlap between patients who were using alcohol, cannabis patients who were using alcohol, cannabis and other drugs limits analysis of the influand other drugs limits analysis of the influence of a particular substance. However, ence of a particular substance. However, the results of the linear regression analysis the results of the linear regression analysis suggest that cannabis use is more strongly suggest that cannabis use is more strongly associated with earlier onset of psychosis associated with earlier onset of psychosis than either alcohol misuse or other drug than either alcohol misuse or other drug , 2004) . Both the prevalence and the profile of substances used by lence and the profile of substances used by the participants in our sample are similar the participants in our sample are similar to those reported in previous out-patient to those reported in previous out-patient and community studies of schizophrenia and community studies of schizophrenia in the UK (e.g. Duke in the UK (e.g. Duke et al et al, 1994 Duke et al et al, , 2001 , 1994 , 2001 Condren Condren et al et al, 2001) , with nicotine, alcohol , 2001), with nicotine, alcohol and cannabis being most commonly used, and cannabis being most commonly used, but stimulants and hallucinogens also being but stimulants and hallucinogens also being popular. When considering the extent to popular. When considering the extent to which our findings can be generalised, it which our findings can be generalised, it might be argued that the prevalence figures might be argued that the prevalence figures for comorbid substance use in patients with for comorbid substance use in patients with schizophrenia in London tend to be higher schizophrenia in London tend to be higher than those in many other parts of the UK than those in many other parts of the UK (Weaver (Weaver et al et al, 2003) . , 2003). The high prevalence of tobacco The high prevalence of tobacco smoking that was found in our study is smoking that was found in our study is consistent with evidence that this habit is consistent with evidence that this habit is particularly strongly associated with particularly strongly associated with schizophrenia compared with other forms schizophrenia compared with other forms of severe mental illness, and that smokingof severe mental illness, and that smokingrelated diseases are more common in related diseases are more common in people with schizophrenia than in the people with schizophrenia than in the general population (DeLeon general population (DeLeon et al et al, 2002) . , 2002). The reasons why people with schizophrenia The reasons why people with schizophrenia tend to be heavy smokers remain uncertain, tend to be heavy smokers remain uncertain, but possible explanations relate to a but possible explanations relate to a therapeutic effect of nicotine on psychotic therapeutic effect of nicotine on psychotic symptoms and/or the neurocognitive symptoms and/or the neurocognitive deficits associated with the disorder, or to deficits associated with the disorder, or to an increase in the metabolism of antian increase in the metabolism of antipsychotic drugs with smoking, causing a psychotic drugs with smoking, causing a reduction in the side-effect burden (Jeste reduction in the side-effect burden (Jeste et al et al, 1996) . The latter explanation would , 1996). The latter explanation would not appear to be relevant to the patients not appear to be relevant to the patients in our sample, as they were already smokin our sample, as they were already smoking when they first presented to psychiatric ing when they first presented to psychiatric services, which suggests that there is a services, which suggests that there is a relationship with the psychotic illness relationship with the psychotic illness rather than with the medication. rather than with the medication.
Assessment of substance Assessment of substance use by self-report use by self-report Self-reported data on substance use can Self-reported data on substance use can provide a reliable and valid basis for provide a reliable and valid basis for prevalence estimation (Weaver prevalence estimation (Weaver et al et al, , 2003) , and such an assessment method 2003), and such an assessment method has the potential to gather information on has the potential to gather information on past use. For example, the self-report past use. For example, the self-report time-line follow-back procedure (Sobell time-line follow-back procedure (Sobell et et al al, 2001 ) for evaluating retrospective self-, 2001) for evaluating retrospective selfreported estimates of daily alcohol conreported estimates of daily alcohol consumption can be reliably used by clinicians sumption can be reliably used by clinicians and researchers to collect information on and researchers to collect information on drinking habits drinking habits up to 12 months before up to 12 months before the interview. A limitation of the present the interview. A limitation of the present study is that our enquiries about past substudy is that our enquiries about past substance use did not include detailed assessstance use did not include detailed assessment of the frequency and amounts of ment of the frequency and amounts of illicit drugs taken, as well as dependency. illicit drugs taken, as well as dependency. It remains uncertain whether precise inforIt remains uncertain whether precise information on the frequency, intensity and timmation on the frequency, intensity and timing of use of the full range of substances ing of use of the full range of substances reported, sometimes over periods of several reported, sometimes over periods of several years, could have been reliably gathered years, could have been reliably gathered retrospectively. The lack of such data retrospectively. The lack of such data means that some of the patients with a hismeans that some of the patients with a history of lifetime substance use who were tory of lifetime substance use who were identified in this study may have been infreidentified in this study may have been infrequent users. However, the evidence sugquent users. However, the evidence suggests that even relatively low levels of gests that even relatively low levels of comorbid substance use are associated with comorbid substance use are associated with a poorer outcome in schizophrenia, includa poorer outcome in schizophrenia, including a greater risk of relapse and a poorer ing a greater risk of relapse and a poorer response to conventional antipsychotic response to conventional antipsychotic medication (Drake & Brunette, 1998; medication (Drake & Brunette, 1998; Kavanagh Kavanagh et al et al, 2004) , and this seems to , 2004), and this seems to hold true for first-episode patients, even in hold true for first-episode patients, even in the short term (Caspari, 1999 ; Sorbara the short term (Caspari, 1999; Sorbara et et al al, 2003) .
, 2003).
Symptom and cognitive correlates Symptom and cognitive correlates of comorbid substance use of comorbid substance use
The finding of a significantly higher mean The finding of a significantly higher mean CGI score in those using substances is CGI score in those using substances is consistent with numerous previous reports consistent with numerous previous reports of more severe illness in people with schizoof more severe illness in people with schizophrenia and comorbid substance use phrenia and comorbid substance use (Brunette (Brunette et al et al, 1997) . However, there , 1997). However, there was no significant association with positive was no significant association with positive psychotic symptoms, which may partly repsychotic symptoms, which may partly reflect the fact that positive symptoms would flect the fact that positive symptoms would have been present in virtually all of the have been present in virtually all of the patients in the sample, as the mental state patients in the sample, as the mental state assessments were usually conducted during assessments were usually conducted during the first admission to hospital with overt the first admission to hospital with overt psychosis. Our findings do not suggest that psychosis. Our findings do not suggest that substance use has an effect on the presentasubstance use has an effect on the presentation of other symptoms. An association tion of other symptoms. An association between comorbid substance use and less between comorbid substance use and less severe negative symptoms has been severe negative symptoms has been reported in several previous studies of reported in several previous studies of patients with schizophrenia (Brunette patients with schizophrenia (Brunette et et al al, 1997), but has not consistently emerged , 1997), but has not consistently emerged in first-episode studies (Linszen in first-episode studies (Linszen et al et al, 1994; , 1994; Hambrecht & Hafner, 1996; Sevy Hambrecht & Hä fner, 1996; Sevy et al et al, , 2001 ). We did not find such an association 2001). We did not find such an association in the present study. Similarly, we found no in the present study. Similarly, we found no relationship between substance use and relationship between substance use and depressive features. Several previous studies depressive features. Several previous studies of patients with established schizophrenia of patients with established schizophrenia have more commonly found depressive have more commonly found depressive symptoms in individuals with comorbid symptoms in individuals with comorbid substance use, but such an association has substance use, but such an association has not been a feature of studies of first-episode not been a feature of studies of first-episode psychosis (Linszen psychosis (Linszen et al et al, 1994; Sevy , 1994; Sevy et al et al, , 2001 ).
2001).
Previous findings that substance use Previous findings that substance use was associated with significantly better prewas associated with significantly better premorbid cognitive functioning and higher morbid cognitive functioning and higher current full-scale IQ prompted the theory current full-scale IQ prompted the theory that first-episode patients who have used that first-episode patients who have used substances may have been better able to obsubstances may have been better able to obtain them because they had more opportutain them because they had more opportunity, greater resources and possibly better nity, greater resources and possibly better social skills (Salyers & Mueser, 2001 ; Sevy social skills (Salyers & Mueser, 2001; Sevy et al et al, 2001 ). This hypothesis is not sup-, 2001 ). This hypothesis is not supported by the findings of our study. Comported by the findings of our study. Comparison of patients with and without parison of patients with and without comorbid substance use revealed no significomorbid substance use revealed no significant differences with regard to premorbid cant differences with regard to premorbid IQ (as estimated by the NART), current IQ (as estimated by the NART), current full-scale IQ or performance on the tests full-scale IQ or performance on the tests of memory and executive function. Furtherof memory and executive function. Furthermore, the two groups were rated as having more, the two groups were rated as having similar levels of social function. Our data similar levels of social function. Our data are consistent with those of Pencer & are consistent with those of Pencer & Addington (2003) , who also found no Addington (2003) , who also found no association between mild-to-moderate subassociation between mild-to-moderate substance misuse and cognitive impairment in stance misuse and cognitive impairment in patients with first-episode psychosis. They patients with first-episode psychosis. They suggested that any deleterious or specific efsuggested that any deleterious or specific effect of substance use on cognition in people fect of substance use on cognition in people with schizophrenia occurs only after prowith schizophrenia occurs only after prolonged use. We have previously found that longed use. We have previously found that a lower premorbid IQ is associated with a lower premorbid IQ is associated with an earlier age at onset (Joyce an earlier age at onset (Joyce et al et al, 2005) . , 2005). In the current patient sample, a regression In the current patient sample, a regression analysis revealed that premorbid IQ analysis revealed that premorbid IQ and substance misuse were independent and substance misuse were independent predictors of earlier age at onset. predictors of earlier age at onset.
Adherence to treatment Adherence to treatment
In patients with established schizophrenia, In patients with established schizophrenia, comorbid substance use has been shown comorbid substance use has been shown to be a major determinant of adherence to to be a major determinant of adherence to treatment (Olfson treatment (Olfson et al et al, 2000) . The poorer , 2000). The poorer prognosis, particularly the higher relapse prognosis, particularly the higher relapse rate, in people with schizophrenia who rate, in people with schizophrenia who use substances may be partly explained by use substances may be partly explained by reduced adherence to the medication regireduced adherence to the medication regimen. However, in the sample of patients men. However, in the sample of patients that we studied, we found no relationship that we studied, we found no relationship between attitudes to medication that are between attitudes to medication that are relevant to adherence (as assessed by the relevant to adherence (as assessed by the ROMI) and substance use. These findings ROMI) and substance use. These findings suggest that, among people with schizosuggest that, among people with schizophrenia, a history of substance use at the phrenia, a history of substance use at the time of first presentation to psychiatric time of first presentation to psychiatric services does not reliably identify those services does not reliably identify those individuals who already have negative individuals who already have negative attitudes to medication and treatment. attitudes to medication and treatment.
Clinical implications Clinical implications
These results confirm the high prevalence These results confirm the high prevalence of lifetime substance use in first-episode paof lifetime substance use in first-episode patients with schizophrenia. Although alcohol tients with schizophrenia. Although alcohol and cannabis were the substances most and cannabis were the substances most commonly used, most patients reported a commonly used, most patients reported a history of multiple substance use. From a history of multiple substance use. From a clinical perspective, given that such subclinical perspective, given that such substance use tends to predict a poorer initial stance use tends to predict a poorer initial outcome, our findings reinforce the need outcome, our findings reinforce the need to routinely assess and consider appropriate to routinely assess and consider appropriate intervention for substance use in people intervention for substance use in people with schizophrenia when they first present with schizophrenia when they first present to pyschiatric services. to pyschiatric services. Birchwood, M., Smith, J., Cochrane, R., Birchwood, M., Smith, J., Cochrane, R., et al et al (1990) 
The Social Functioning Scale. Retrospective assessment of the duration of untreated psychosis should take account of the possible confounding effect of symptoms related to substance use. account of the possible confounding effect of symptoms related to substance use.
LIMITATIONS LIMITATIONS
& & The study population consisted of an urban sample of patients in the UK, and this
The study population consisted of an urban sample of patients in the UK, and this limits the extent to which the findings can be generalised. limits the extent to which the findings can be generalised. 
